FDA panel votes 3-14 that Abbott (ABT) has not found right Humira dose
FDA panel votes 3-14 that Abbott (NYSE: ABT) has not found right Humira dose.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott's (ABT) FreeStyle Libre Pro System Approved by U.S. FDA
- Alere (ALR) says mediation with Abbott (ABT) concluded without resolution - Bloomberg
- Yellen Says Has Never Seen Politics Enter Fed Policy Debate; Gov. Brainard Acting in Way Consistent with Rules
Create E-mail Alert Related CategoriesFDA, General News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!